搜索
Cryoport Inc
CYRX添加自选
15.860USD
+0.160+1.02%
收盘 07/01, 16:00（美东）报价延迟15分钟
799.38M总市值
11.07市盈率 TTM
关键数据
15.660今开
16.650最高
1.14M成交量
11.07市盈率 TTM
亏损市盈率动
--股息TTM
2.27%换手率
15.700昨收
15.585最低
13.95M成交额
亏损市盈率静
1.77市净率
0.00%股息率 TTM
-5.01%ROA
15.29052周最高
0.96量比
-122.76M净利润
50.20M总股本
1.4325每股收益TTM
1.87Beta
-10.98%ROE
5.31052周最低
6.78%振幅
45.85%毛利率
799.38M总市值
-0.07回报/风险
3.43%风险率
TradingKey Cryoport Inc股票评分
单位: USD 更新时间: 2026-07-01操作建议
Cryoport Inc当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在货运与物流服务行业排名4/78位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价15.30。中期看，股价处于上升通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Cryoport Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看好
Cryoport Inc亮点
亮点风险
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
业绩转盈
公司业绩转盈，最新年度盈利美元
估值高估
公司最新PB估值1.77，处于3年历史高位
机构减仓
最新机构持股49.22M股，环比减少18.53%
HACAX持仓
明星投资者HACAX持仓，最新持仓市值25.00K
活跃度增加
近期活跃度增加，过去20天平均换手率0.66
分析师目标
根据
10
位分析师
买入
评级
15.300
目标均价
-2.55%
涨幅空间
Cryoport Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Cryoport Inc简介
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
公司代码CYRX
公司Cryoport Inc
CEOShelton (Jerrell Wilson)
网址https://www.cryoport.com/
相关品种
+2.12%
+1.90%
+1.68%
-0.76%
+0.27%
+0.47%
+1.40%
-0.67%
+0.63%
-0.63%
-1.96%
+0.22%
-1.81%
+0.93%
+1.56%
+2.36%
+3.19%
+1.81%
-2.32%
-0.63%热门品种
常见问题
Cryoport Inc(CYRX)的当前股价是多少？
Cryoport Inc(CYRX)的当前股价是 15.86。
Cryoport Inc的股票代码是什么？
Cryoport Inc的股票代码是CYRX。
Cryoport Inc股票的52周最高点是多少？
Cryoport Inc股票的52周最高点是15.29。
Cryoport Inc股票的52周最低点是多少？
Cryoport Inc股票的52周最低点是5.31。
Cryoport Inc的市值是多少？
Cryoport Inc的市值是796.14M。
现在Cryoport Inc(CYRX)的股票是买入、持有还是卖出？
根据分析师评级，Cryoport Inc(CYRX)的总体评级为买入，目标价格为15.30。
Cryoport Inc(CYRX)股票的每股收益（EPS TTM）是多少
Cryoport Inc(CYRX)股票的每股收益（EPS TTM）是1.40。